‘Mini Tumors’ from Patient Samples Could Help Personalize Cancer Drug Treatment

News   Feb 23, 2018 | Original story from ICR

 
‘Mini Tumors’ from Patient Samples Could Help Personalize Cancer Drug Treatment

Credit: ICR

 
 
 

RELATED ARTICLES

Watching Stem Cells Repair Spinal Cord in Real Time

News

Clues to the reversal of brain and spine injury.

READ MORE

Research Team Discovers Compound that Stops Cancer From Spreading

News

Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.

READ MORE

PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

News

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.

READ MORE

 

Comments | 1 ADD COMMENT

Ken Dixon | Mar 21, 2018

My name is Ken Dixon, and I am a cancer surgeon and the founder of SpeciCare (www.specicare.com), a company that provides personalized cancer care solutions. We help patients take control of their tumor tissue by storing it in multiple formats. Thank you for highlighting the advances in personalized cancer care and helping people understand the importance of NOT allowing surgeons to throw their tumor tissue away.


Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy